COVID-19 morbidity decreases with tixagevimab-cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders.
Kaminski H, Gigan M, Vermorel A, Charrier M, Guirle L, Jambon F, Lacapère A, Ménard C, Moreau K, Neau-Cransac M, Novion M, Pribat F, Taton B, Borde S, Burguet L, Martinez C, Jasiek M, D'Halluin P, Lafon ME, Merville P, Couzi L.
Kaminski H, et al. Among authors: neau cransac m.
Kidney Int. 2022 Oct;102(4):936-938. doi: 10.1016/j.kint.2022.07.008. Epub 2022 Jul 20.
Kidney Int. 2022.
PMID: 35870641
Free PMC article.
No abstract available.